10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 2 filers reported holding 10X GENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $766,590 | -28.0% | 18,584 | -2.6% | 0.02% | -30.3% |
| Q2 2023 | $1,065,204 | +0.1% | 19,076 | -0.0% | 0.03% | -10.8% |
| Q1 2023 | $1,064,306 | +67.9% | 19,077 | +9.7% | 0.04% | +42.3% |
| Q4 2022 | $633,837 | -19.8% | 17,394 | -0.4% | 0.03% | -29.7% |
| Q2 2022 | $790,000 | +237.6% | 17,461 | +468.4% | 0.04% | +236.4% |
| Q1 2022 | $234,000 | +8.3% | 3,072 | +179.0% | 0.01% | -52.2% |
| Q2 2021 | $216,000 | – | 1,101 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
| Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
| Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
| Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
| Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
| Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
| RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
| Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
| Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |